190 related articles for article (PubMed ID: 17520676)
21. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
[TBL] [Abstract][Full Text] [Related]
22. Sequential caspase-2 and caspase-8 activation is essential for saikosaponin a-induced apoptosis of human colon carcinoma cell lines.
Kim BM; Hong SH
Apoptosis; 2011 Feb; 16(2):184-97. PubMed ID: 21107704
[TBL] [Abstract][Full Text] [Related]
23. Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8.
Kovar H; Jug G; Printz D; Bartl S; Schmid G; Wesierska-Gadek J
Oncogene; 2000 Aug; 19(36):4096-107. PubMed ID: 10962570
[TBL] [Abstract][Full Text] [Related]
24. Ponicidin, an ent-kaurane diterpenoid derived from a constituent of the herbal supplement PC-SPES, Rabdosia rubescens, induces apoptosis by activation of caspase-3 and mitochondrial events in lung cancer cells in vitro.
Liu JJ; Huang RW; Lin DJ; Peng J; Zhang M; Pan X; Hou M; Wu XY; Lin Q; Chen F
Cancer Invest; 2006 Mar; 24(2):136-48. PubMed ID: 16537182
[TBL] [Abstract][Full Text] [Related]
25. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
Motwani M; Delohery TM; Schwartz GK
Clin Cancer Res; 1999 Jul; 5(7):1876-83. PubMed ID: 10430095
[TBL] [Abstract][Full Text] [Related]
26. The apoptotic effects of oxidative stress and antiapoptotic effects of caspase inhibitors on rat notochordal cells.
Kim KW; Ha KY; Lee JS; Rhyu KW; An HS; Woo YK
Spine (Phila Pa 1976); 2007 Oct; 32(22):2443-8. PubMed ID: 18090083
[TBL] [Abstract][Full Text] [Related]
27. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol.
Li Y; Bhuiyan M; Alhasan S; Senderowicz AM; Sarkar FH
Clin Cancer Res; 2000 Jan; 6(1):223-9. PubMed ID: 10656453
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors.
Sakimura R; Tanaka K; Nakatani F; Matsunobu T; Li X; Hanada M; Okada T; Nakamura T; Matsumoto Y; Iwamoto Y
Int J Cancer; 2005 Sep; 116(5):784-92. PubMed ID: 15849726
[TBL] [Abstract][Full Text] [Related]
30. Involvement of mitochondria and caspase pathways in N-demethyl-clarithromycin-induced apoptosis in human cervical cancer HeLa cell.
Qiao AM; Ikejima T; Tashiro S; Onodera S; Zhang WG; Wu YL
Acta Pharmacol Sin; 2006 Dec; 27(12):1622-9. PubMed ID: 17112418
[TBL] [Abstract][Full Text] [Related]
31. Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells.
Blagosklonny MV
Leukemia; 2001 Jun; 15(6):936-41. PubMed ID: 11417480
[TBL] [Abstract][Full Text] [Related]
32. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
Zi X; Simoneau AR
Cancer Res; 2005 Apr; 65(8):3479-86. PubMed ID: 15833884
[TBL] [Abstract][Full Text] [Related]
33. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931
[TBL] [Abstract][Full Text] [Related]
34. Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential.
Lahusen T; De Siervi A; Kunick C; Senderowicz AM
Mol Carcinog; 2003 Apr; 36(4):183-94. PubMed ID: 12669310
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: activation of the mitochondria-dependent death-signaling pathway.
Nguyen DM; Schrump WD; Tsai WS; Chen A; Stewart JH; Steiner F; Schrump DS
J Thorac Cardiovasc Surg; 2003 May; 125(5):1132-42. PubMed ID: 12771887
[TBL] [Abstract][Full Text] [Related]
36. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
Gojo I; Zhang B; Fenton RG
Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644
[TBL] [Abstract][Full Text] [Related]
37. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; RĂ©dini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
38. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis.
Wittmann S; Bali P; Donapaty S; Nimmanapalli R; Guo F; Yamaguchi H; Huang M; Jove R; Wang HG; Bhalla K
Cancer Res; 2003 Jan; 63(1):93-9. PubMed ID: 12517783
[TBL] [Abstract][Full Text] [Related]
39. [Synergism of antitumor effects on ovarian carcinoma using autocatalytic caspase-3 combined with flavopiridol].
Song Y; Shen K; Xu F
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):781-6. PubMed ID: 21176562
[TBL] [Abstract][Full Text] [Related]
40. Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment.
Bright SA; Campiani G; Deininger MW; Lawler M; Williams DC; Zisterer DM
Biochem Pharmacol; 2010 Jul; 80(1):31-8. PubMed ID: 20206141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]